Heiss P, Zorger N, Kaempfe I, Jung E M, Pfister K, Paetzel C, Feuerbach S, Herold T
Institut für Röntgendiagnostik, Universität Regensburg.
Rofo. 2008 Oct;180(10):906-14. doi: 10.1055/s-2008-1027699.
To evaluate the technical and clinical success rates of percutaneous stent revascularization in the treatment of chronic mesenteric ischemia (CMI).
17 patients (12 female) with typical symptoms of CMI were treated by percutaneous stent placement for stenoses of the splanchnic arteries (celiac trunk; superior mesenteric artery, SMA; inferior mesenteric artery, IMA). The primary and secondary technical success, primary and secondary clinical success, and the long-term clinical outcome were determined.
A total of 24 stents were implanted in 21 splanchnic arteries (12 stents in the celiac trunk, 11 in the SMA and 1 in the IMA). The primary technical success rate was 91% (19/21 arteries), the secondary technical success rate was 95% (21/22 arteries). Clinical follow-up was available for 16 patients. The primary clinical success rate was 81% (13/16 patients). Following two secondary interventions, the secondary clinical success rate was 94% (15/16 patients). Long-term clinical success was achieved in 15 of 16 patients (94%) with a mean follow-up of 26 months. One patient died within 30 days of the intervention and two patients demonstrated major complications (1 dissection, 1 stent dislocation). None of the patients required surgical revascularization and none of the patients died due to recurrent mesenteric ischemia.
Percutaneous stent placement for the treatment of CMI can be performed with a high technical and clinical success rate as well as an excellent long-term clinical outcome.
评估经皮支架血管重建术治疗慢性肠系膜缺血（CMI）的技术成功率和临床成功率。
17例有CMI典型症状的患者（12例女性）因内脏动脉（腹腔干、肠系膜上动脉[SMA]、肠系膜下动脉[IMA]）狭窄接受经皮支架置入术。确定初次和二次技术成功率、初次和二次临床成功率以及长期临床结局。
共在21条内脏动脉中植入24枚支架（腹腔干12枚、SMA 11枚、IMA 1枚）。初次技术成功率为91%（21条动脉中的19条），二次技术成功率为95%（22条动脉中的21条）。16例患者有临床随访资料。初次临床成功率为81%（16例患者中的13例）。经过两次二次干预后，二次临床成功率为94%（16例患者中的15例）。16例患者中有15例（94%）获得长期临床成功，平均随访26个月。1例患者在干预后30天内死亡，2例患者出现严重并发症（1例夹层、1例支架移位）。无患者需要外科血管重建，无患者因肠系膜缺血复发死亡。
经皮支架置入术治疗CMI技术成功率和临床成功率高，长期临床结局良好。
